CAS 361442-04-8 Maʻemaʻe >99.0% (HPLC) API
ʻO Ruifu Chemical Supply pili i waena
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Nā huaʻōlelo like | BMS-477118;Onglyza;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-Carbonitrile;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane -3-Carbonitrile |
Helu CAS | 361442-04-8 |
Helu CAT | RF-PI1991 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C18H25N3O2 |
Kaumaha Molecular | 315.41 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Pauda keʻokeʻo |
ʻala | ʻano ʻano |
ʻike ʻike | A: IR B: Manawa Paʻa HPLC |
Maʻemaʻe / Kaʻina Hanana | >99.0% (HPLC) |
Malamalama o ka Wai | Alohilohi, kala ʻole, ʻaʻohe mea i hoʻopaʻa ʻia |
Anana Anaina | 100% Holo i ka 80 Mesh |
Lae hehee | 202.0~212.0 ℃ |
Nalo ma ka maloo | <0.50% |
Lehu Sulphated | <0.20% |
Hoʻololi kikoʻī | +174.0°~+186.0° |
Hoʻokahi haumia | <0.50% |
Huina paumaele | <1.00% |
Nā Metala Kaumaha | <10ppm |
Arsenic (As) | <2.0ppm |
Ke kēpau (Pb) | <1.0ppm |
Cadmium (Cd) | <1.0ppm |
Nā mea hoʻoheheʻe koena | <100ppm |
Pesticide koena | ʻinoʻino |
Microbiology | |
Huina Papa | <1000cfu/g |
Huna & Mold | <100cfu/g |
E. Coli | ʻinoʻino |
S. Aureus | ʻinoʻino |
Salmonella | ʻinoʻino |
Ola Pahu | 24 mau mahina mai ka lā hana inā mālama pono ʻia |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | API;ʻO ka maʻi maʻi diabetes type 2 |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
(BMS-477118) (CAS: 361442-04-8) he mea ikaika, koho, hoʻololi, hoʻokūkū a me ka waha i ka dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) mea hoʻonā.Loaʻa iā BMS-477118 ka peotential no ka noiʻi maʻi diabetes type 2.BMS-477118he lāʻau maʻi diabetes type 2 hiki ke hoʻoulu i ka pancreas e hana hou aku i ka insulin ma hope o ka ʻai ʻana.Ua hōʻea ʻia e ka hui pū ʻana o AstraZeneca a me Bristol-Myers Squibb Company a nona ka DPP-IV inhibitor.BMS-477118pāʻani i ka hana ma o ka pale ʻana i ka hoʻohaʻahaʻa GLP-l.ʻO GLP-I nā hormones i hana maoli ʻia i loko o ka ʻōpū ma hope o ka ʻai ʻana i ka meaʻai.Hiki iā ia ke hoʻoponopono i ka huna ʻana o ka insulin a hoʻoikaika i ka hoʻohana ʻana i ka glucose i loko o nā ʻiʻo peripheral.Hiki i ka lāʻau lapaʻau hoʻokahi o BMS-477118 ke hoʻomaikaʻi i ka mana glucose koko a me ka lāʻau lapaʻau hui pū ʻia o BMS-477118 me Metformin, Sulfonylurea a me Thiazolidinediones hiki ke hoʻonui i ka hopena curative.Ke alakaʻi nei ia i ka haʻahaʻa haʻahaʻa o ka hypoglycemia a me kāna mau hopena ʻino e like me ka placebo, e hōʻike ana i ka hoʻomanawanui ʻoi aku ka maikaʻi.Ma Iulai 31, 2009, BMS-477118 nā papa (Onglyza), he lāʻau lapaʻau hou o ka maʻi diabetes type 2, i noiʻi pū ʻia a hoʻomohala ʻia ʻo AstraZeneca a me Bristol-Myers Squibb i ʻae ʻia e ka US FDA.Hiki ke lawe ʻia i hoʻokahi lā no ka mālama ʻana i ka maʻi diabetes type 2 i hui pū ʻia me ka mālama ʻana i ka meaʻai a me ka hoʻoikaika kino.